MDxHealth S.A. (MDXH) vs Rockwell Medical, Inc. (RMTI)

A side-by-side comparison of MDxHealth S.A. and Rockwell Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — MDXH vs RMTI

growth of $100 · dividends reinvested · last 5y
MDXH -95.0% (-45.1%/yr)RMTI -86.4% (-32.9%/yr)RMTI compounded faster over this window
020406080100Start $10020222023202420252026$5$14
MDXH RMTI

MDXH vs RMTI: by the numbers

  • •RMTI is the larger company ($32M vs $31M market cap).
  • •Both run net losses; RMTI's is the smaller (-7.33% vs -31.07% net margin).
  • •MDXH grew revenue faster over the past five years (42.35% vs 2.59% CAGR).

Metrics side by side

Valuation

MetricMDXHRMTI
P/S ratioN/A0.47
P/B ratioN/A0.92
FCF yieldN/A4.77%

Profitability

MetricMDXHRMTI
Gross margin59.74%17.71%
Operating margin-14.28%-6.52%
Net margin-31.07%-7.33%
ROEN/A-14.49%
ROIC-15.35%-9.60%

Growth (annualized)

MetricMDXHRMTI
Revenue CAGR (5Y)42.35%2.59%
Total return CAGR (5Y)N/A-33.38%

Frequently asked

Which has grown faster, MDXH or RMTI?
Over the past five years, MDXH grew revenue faster — MDXH at a 42.35% CAGR versus RMTI at 2.59%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.